How telehealth allergy care works

Telehealth allergy clinics typically diagnose environmental allergies (pollen, dust mites, pet dander, molds) and offer immunotherapy to retrain the immune system for long‑term relief. Two evidence‑based delivery options exist:

Allergy shots (subcutaneous immunotherapy, SCIT) administered in a clinic with a required post‑injection observation period due to rare anaphylaxis risk. Relief often starts after 6–12 months; full course is usually 3–5 years. Harvard Health overview on allergy shots and why clinics require a 30‑minute wait.
Sublingual immunotherapy (SLIT) given as tablets or custom drops under the tongue at home. Multiple systematic reviews and major society guidance show SLIT is effective and generally has a lower severe‑reaction risk than shots; tablets are FDA‑approved for select allergens (certain grasses, ragweed, dust mite), while multi‑allergen drops are widely used off‑label in the U.S. See SLIT vs. shots, AAO‑HNS/clinical support summarized, and safety notes on severe reactions being exceedingly rare with SLIT compared to shots (risk discussion, safety FAQ).

Why this matters now:

Allergies affect a large share of U.S. adults and children, and seasons are lengthening in many regions. See prevalence data from CDC FastStats and climate‑pollen impacts from the CDC Climate & Health allergens page.

What to evaluate in a telehealth allergy clinic

Use the checklist below to compare providers:

Medical oversight: Board‑certified physicians directing care; clear escalation plan; 24/7 access for urgent questions. See example expectations in a telehealth allergy FAQ: clinic FAQs.
First‑dose policy for SLIT tablets: FDA‑approved tablets (e.g., grass, ragweed, dust mite) require the first dose under clinician supervision; confirm the clinic’s protocol for in‑office or local partner supervision and emergency readiness. See general background on shots wait/safety as a benchmark: in‑office monitoring rationale.
FDA status and disclosures: SLIT tablets are FDA‑approved for specific allergens; custom multi‑allergen SLIT drops are used off‑label in the U.S. A traditional clinic perspective noting drops are not FDA‑approved is here: Family Allergy & Asthma FAQ. Also review evidence summaries indicating comparable efficacy between shots and SLIT when appropriately dosed: comparative overview and SLIT program detail.
Testing quality: CLIA‑certified lab for blood IgE tests; acceptance of recent external test results; clear plan to reconcile test findings with clinical history. Example of at‑home CLIA test workflow: at‑home allergy test.
Scope of treatment: Environmental allergens only (most telehealth clinics do not treat food allergy with SLIT). Shots and SLIT address environmental triggers; verify contraindications and pediatric eligibility (many programs treat ages 5+). See a typical scope/age policy: program FAQ.
Safety program: Written anaphylaxis plan, training, and whether an epinephrine auto‑injector is required or recommended for first doses; documentation of serious‑event rates; post‑dose guidance.
Access & follow‑up: Response SLAs; scheduled check‑ins; medication refills; education resources.
Pricing & coverage: Transparent monthly or membership pricing; what’s included (physician visits, shipping, refills); insurance treatment coverage (often limited for SLIT drops in the U.S.); HSA/FSA eligibility; cancellation/refund terms. Cost context for shots vs SLIT is summarized here: shots vs SLIT cost and logistics and cost of shots.
Outcome timeline and duration: Expected onset of improvement (often 4 weeks–6 months for SLIT) and total therapy length (commonly ~3 years for durable benefit). See onset/duration examples: how long until drops work and program timeline.

Buyer’s checklist (print or copy into your notes)

Criterion	Questions to ask	Preferred standard
Physician oversight	Are board‑certified physicians directing my care? Is 24/7 support available?	MD/DO oversight; clear escalation pathways
First‑dose tablet policy	Where is the first SLIT tablet dose administered? Who monitors and what emergency gear is on hand?	Supervised first dose per labeling; documented anaphylaxis plan
FDA status disclosures	Are you using FDA‑approved tablets vs. off‑label multi‑allergen drops? Is this disclosed in consent?	Clear FDA/off‑label disclosure and consent
Evidence & guidelines	What evidence supports your dosing protocols?	References to major reviews/guidelines and internal SOPs
Testing	Is your lab CLIA‑certified? Will you accept recent external results?	CLIA‑certified; accepts recent third‑party results
Safety profile	What’s your severe‑reaction rate and Epi policy?	Transparent safety stats; Epi policy for first doses
Pediatrics & contraindications	What ages do you treat? How do you screen for EoE, MCAS, beta blockers, pregnancy?	Ages 5+ common; standardized screening
Access & follow‑up	How often do clinicians check in? What’s refill turnaround?	Scheduled check‑ins; timely refills
Pricing	What does the monthly or membership fee include? Any add‑on fees?	Transparent, all‑in pricing; HSA/FSA accepted
Insurance	What does insurance cover (testing, visits, shots/tablets vs drops)?	Upfront coverage guidance; receipts for reimbursement
Guarantees	Do you offer a satisfaction window or money‑back terms?	Clear, time‑bounded guarantee terms
Timeline & goals	When should I expect improvement? How long is the full course?	Onset 4–24 weeks; ~3 years for durable benefit

Therapy options at a glance (know the differences before you choose)

Allergy shots (SCIT)
Pros: Long track record; often covered by insurance; customizable multi‑allergen extracts.
Cons: Clinic visits and 30‑minute post‑injection observation required due to rare anaphylaxis risk; time burden; onset can take 6–12 months. Sources: Harvard Health, in‑office wait rationale.
SLIT tablets (FDA‑approved for select allergens)
Pros: At‑home dosing after a supervised first dose; strong evidence base; standardized dosing.
Cons: Each tablet treats a single allergen; coverage varies; first dose must be supervised.
Background: SLIT program details.
SLIT drops (multi‑allergen, U.S. off‑label)
Pros: Needle‑free at home; can address multiple allergens simultaneously; favorable safety profile reported in the literature.
Cons: Off‑label in the U.S.; insurance coverage limited; requires clinic‑defined dosing protocols and informed consent. Perspectives from both sides: traditional clinic position and comparative evidence summary.

Due‑diligence questions you can copy/paste to any provider

1) Who is the supervising physician for my case and what is their board certification? 2) For SLIT tablets, where is my first dose administered and who monitors me? What’s your Epi policy? 3) Are you prescribing FDA‑approved tablets, off‑label drops, or a combination? How do you explain the differences in consent? 4) Which guidelines and studies underpin your dosing? Can you share patient education that cites these sources? (Example evidence summaries: SLIT vs shots). 5) Is your test CLIA‑certified? Will you accept my recent results from another lab/clinic? 6) What’s included in the monthly or membership price (visits, shipping, refills, check‑ins)? Any add‑on charges? 7) What does insurance typically cover here (tests, visits, shots/tablets vs drops)? Are HSA/FSA accepted? 8) What contraindications or age limits do you follow? (Common exclusions include pregnancy, certain medications, EoE/MCAS.) 9) When should I expect improvement and what is the total treatment duration you target? 10) Do you publish safety metrics (e.g., severe‑reaction rates) and how do you handle after‑hours concerns?

Red flags to watch for

No supervised first‑dose policy for SLIT tablets despite FDA labeling.
No mention of FDA status/off‑label disclosure when offering multi‑allergen drops.
Vague pricing or per‑allergen up‑charges that are not disclosed upfront.
Lack of CLIA certification for laboratory testing.
No written safety protocol or unclear anaphylaxis plan.

FAQs

Are SLIT drops FDA‑approved in the U.S.? No. Custom multi‑allergen SLIT drops are commonly used off‑label in the U.S., while tablets for specific allergens (certain grasses, ragweed, dust mite) are FDA‑approved. Some traditional clinics emphasize drops’ non‑approval status; review informed‑consent language and evidence provided. See traditional clinic FAQ and evidence summary.
Why do some treatments require in‑office observation? Allergy shots carry a rare anaphylaxis risk, so clinics typically observe for ~30 minutes after injections. This standard is one model of safety you can benchmark. See why clinics wait and Harvard Health overview.
How soon should I expect results? With SLIT, many patients report improvement within 4–24 weeks; durable immune change generally takes ~3 years of consistent therapy. See onset expectations and program timelines.
Will a telehealth clinic treat food allergies? Most telehealth immunotherapy programs focus on environmental allergies and do not treat food allergy with SLIT. Confirm scope before enrolling. General allergy prevalence stats: CDC FastStats.
Are SLIT and shots equally effective? Comparative reviews show both can provide long‑term relief when properly dosed and adhered to; the best choice is driven by your allergens, risk profile, access, and preferences. See comparative discussion and a high‑level SLIT vs shots explainer.
What should I ask about testing? Ask whether blood testing is processed by a CLIA‑certified lab, whether you need to stop antihistamines beforehand, and if the clinic will review external results. Example at‑home CLIA test process: details.
How do climate trends affect choosing a clinic? Longer pollen seasons can mean more months of exposure; that raises the value of durable therapies and reliable follow‑up. See CDC climate & allergens.

Tip: Add this page to your Learning Center to give patients and care teams a neutral, citable framework for evaluating telehealth allergy providers.

How to choose a telehealth allergy clinic: a neutral buyer’s guide (doctor oversight, first‑dose tablet policy, FDA‑approved tablets, price, guarantee)